Edition:
United Kingdom

BB Biotech AG (BION.S)

BION.S on Swiss Exchange

62.15CHF
16 Aug 2019
Change (% chg)

CHF2.00 (+3.33%)
Prev Close
CHF60.15
Open
CHF60.60
Day's High
CHF62.35
Day's Low
CHF60.10
Volume
97,361
Avg. Vol
74,474
52-wk High
CHF74.60
52-wk Low
CHF55.05

Latest Key Developments (Source: Significant Developments)

BB Biotech H1 Net Profit At CHF 554 Mln
Friday, 19 Jul 2019 

July 19 (Reuters) - BB BIOTECH AG ::CONSOLIDATION LEAVES A MARK ON RESULTS IN THE SECOND QUARTER.Q2 NET ASSET VALUE FELL 9.4% IN CHF AND 8.8% IN EUR, RESULTING IN A SECOND-QUARTER NET LOSS OF CHF 336 MN COMPARED TO A LOSS OF CHF 98 MN IN YEAR-AGO PERIOD.ANTICIPATES FURTHER PIPELINE PROGRESS.NET PROFIT FOR PERIOD ENDED JUNE 30, 2019 AMOUNTED TO CHF 554 MN (LOSS OF CHF 70 MN IN H1 2018).  Full Article

BB Biotech Q1 Profit Of CHF 890 Million
Friday, 26 Apr 2019 

April 26 (Reuters) - BB Biotech AG ::Q1 PROFIT OF CHF 890 MN (PROFIT OF CHF 28 MN IN CORRESPONDING PERIOD OF PREVIOUS YEAR).  Full Article

BB Biotech Q3 Profit Down At CHF 242 Mln
Thursday, 11 Oct 2018 

Oct 11 (Reuters) - BB Biotech AG ::FOR NINE MONTHS PERIOD ENDED SEPTEMBER 30, 2018 A PROFIT OF CHF 172 MILLION VERSUS CHF 843 MILLION YEAR AGO.IN Q3 A PROFIT OF CHF 242 MILLION (PROFIT OF CHF 365 MILLION IN CORRESPONDING PERIOD OF PREVIOUS YEAR).  Full Article

BB Biotech FY Net Result Turns to Profit Of CHF 688 Million
Friday, 16 Feb 2018 

Feb 16 (Reuters) - BB BIOTECH AG ::FY NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN IN PREVIOUS PERIOD.‍WILL PROPOSE AN ORDINARY DIVIDEND OF CHF 3.30 PER SHARE​.  Full Article

BB Biotech to propose 3.30 Sfr dividend for 2017
Friday, 19 Jan 2018 

Jan 19 (Reuters) - BB Biotech AG ::SHOWS A DOUBLE-DIGIT TOTAL RETURN FOR 2017 - MID CAPS OVERDELIVER ON INNOVATION AND ARE BECOMING A KEY UPSIDE TRIGGER.‍UNDERLYING PORTFOLIO PERFORMED WELL, ENDING YEAR UP 23.4% IN CHF, 12.5% IN EUR AND 29.2% IN USD​.‍FULL YEAR 2017 DATA SHOWED A NET GAIN OF CHF 688 MN COMPARED TO A NET LOSS OF CHF 802 MN FOR FULL YEAR 2016​.‍WILL PROPOSE A RECORD REGULAR DIVIDEND OF CHF 3.30 PER SHARE AT GENERAL ASSEMBLY ON MARCH 13, 2018​.‍BELIEVES THAT 2018 WILL CONTINUE TO BRING IMPORTANT PRODUCT APPROVALS AND MILESTONES FOR SECTOR AND FOR ITS PORTFOLIO​.  Full Article

BB Biotech Q3 net profit down at CHF 365 million
Friday, 20 Oct 2017 

Oct 20 (Reuters) - BB BIOTECH AG ::PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER.Q3 ‍NET PROFIT AMOUNTED TO CHF 365 MN VERSUS PROFIT OF CHF 392 MN REPORTED IN Q3 LAST YEAR​.  Full Article

Swiss stocks - Factors to watch on July 19

ZURICH/BERLIN, July 19 The Swiss blue-chip SMI was seen opening 0.4 percent higher at 10,047 points on Friday, a level that would be near a record high, according to premarket indications by bank Julius Baer.